Belvedere Trading »

Celldex Therapeutics shares owned by Belvedere Trading

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Belvedere Trading from 13F filings

Historical chart of Belvedere Trading investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by Belvedere Trading consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by Belvedere Trading

Quarter filed Position value Share count Share price at filing
2024-09-30 $207k 6.1k 33.99
2021-09-30 $564k 13k 45.15

More positions owned by Belvedere Trading

Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors (TSLA)
Meta Platforms Cl A (META)
Ishares Tr Russell 2000 Etf (IWM)
Spdr Gold Tr Gold Shs Call Option (GLD)
Apple Call Option (AAPL)
Amazon (AMZN)
Microstrategy Cl A New (MSTR)
Vaneck Etf Trust Semiconductr Etf (SMH)
Advanced Micro Devices (AMD)
Ishares Silver Tr Ishares Call Option (SLV)
Super Micro Computer Com New (SMCI)
Coinbase Global Com Cl A (COIN)

View all positions for Belvedere Trading

Top funds holding Celldex Therapeutics

Wellington Management Company
BlackRock
FMR
Vanguard Group
Eventide Asset Management
T. Rowe Price Associates
Kynam Capital Management
State Street Corporation
Bellevue Group
Polar Capital Holdings
Point72 Asset Management
Leucadia National Corporation
Woodline Partners
T. Rowe Price Investment Management
Commodore Capital

View all funds holding Celldex Therapeutics